Last month, the Israeli Medtech company AIVF made headlines. The developer of an AI-based in vitro fertilization software platform announced it has raised $25 million in a first investment round led by Insight Partners, a New York-based venture capital and private equity firm.

There is a growing interest by Israeli investors and entrepreneurs in this domain. Israel has seen a significant upward trend in IVF treatment, which involves extraction of egg for fertilization before insertion into the patient's uterus. Most patients need to go through more than one treatment cycle before a fertilized egg is implanted.

According to data from the Israeli Ministry of Health, in 1990 fewer than 5,000 treatment cycles took place domestically. In 2010, the figure jumped to about 35,000 and in 2019 it rose to about 52,000. In Israel, about a quarter of cycles end in pregnancy and about a fifth in live births. In recent years, roughly 4% of all live births in Israel have been as a result of IVF treatments.

Israel is the site of the world's largest number of treatments per capita for both social and financial reasons.